# ADDIA Proof-of-Performance Clinical Study

> **NCT03030586** · — · COMPLETED · sponsor: **Amoneta Diagnostics SAS** · enrollment: 821 (actual)

## Conditions studied

- Alzheimer Disease (AD)
- Frontotemporal Lobar Degeneration
- Dementia with Lewy Bodies (DLB)
- Parkinson Disease Dementia (PDD)
- Progressive Supranuclear Palsy (PSP)
- Corticobasal Degeneration (CBD)

## Interventions

- **OTHER:** volumetric MRI

## Key facts

- **NCT ID:** NCT03030586
- **Lead sponsor:** Amoneta Diagnostics SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 821 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03030586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03030586, "ADDIA Proof-of-Performance Clinical Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03030586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*